<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="6631">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02020603</url>
  </required_header>
  <id_info>
    <org_study_id>GUB2013</org_study_id>
    <nct_id>NCT02020603</nct_id>
  </id_info>
  <brief_title>Efficacy of Hemostasis by Soft Coagulation Using Endoscopic Hemostatic Forceps for Acute Peptic Ulcer Bleeding</brief_title>
  <official_title>Efficacy of Hemostasis by Soft Coagulation Using Endoscopic Hemostatic Forceps in Comparison With Argon Plasma Coagulation for Acute Peptic Ulcer Bleeding</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kyunghee University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kyunghee University Medical Center</source>
  <oversight_info>
    <authority>South Korea: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Endoscopic high-frequency soft coagulation is available for the management of bleeding or
      nonbleeding visible vessels during endoscopic submucosal dissection. However, its efficacy
      on peptic ulcer bleeding has not been elucidated so far. The aim of this study was to
      evaluate the efficacy of hemostasis with soft coagulation using hemostatic forceps by
      comparing it with argon plasma coagulation (APC) in a prospective, randomized trial.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2012</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">November 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Recurrence of bleeding within four weeks after initial hemostasis</measure>
    <time_frame>up to 24 months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>initial hemostasis rate</measure>
    <time_frame>up to 24 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">160</enrollment>
  <condition>Active Peptic Ulcer Disease/GI Bleeding</condition>
  <arm_group>
    <arm_group_label>APC group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>epinephrine injection plus argon plasma coagulation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Forceps group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>epinephrine injection plus soft coagulation using hemostatic forceps</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>epinephrine injection plus soft coagulation using hemostatic forceps</intervention_name>
    <arm_group_label>Forceps group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>epinephrine injection plus argon plasma coagulation</intervention_name>
    <arm_group_label>APC group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age greater than 18 years

          -  peptic ulcer with stigmata of recent hemorrhage

        Exclusion Criteria:

          -  malignant ulcer

          -  previous gastric surgery
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jae Young Jang, M.D.</last_name>
    <role>Study Chair</role>
    <affiliation>Kyung-Hee University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jung-Wook Kim, M.D.</last_name>
    <phone>82-10-3109-0175</phone>
    <email>iloveact@hanmail.net</email>
  </overall_contact>
  <location>
    <facility>
      <name>Kyung Hee University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>130-872</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hyo Jong Kim</last_name>
      <phone>82-2-958-8149</phone>
    </contact>
    <investigator>
      <last_name>Jae Young Jang, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>December 19, 2013</lastchanged_date>
  <firstreceived_date>December 15, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kyunghee University Medical Center</investigator_affiliation>
    <investigator_full_name>Jung-Wook Kim</investigator_full_name>
    <investigator_title>Clinical fellow</investigator_title>
  </responsible_party>
  <keyword>peptic ulcer bleeding</keyword>
  <keyword>hemostatic forceps</keyword>
  <keyword>soft coagulation</keyword>
  <keyword>argon plasma coagulation</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Gastrointestinal Hemorrhage</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Peptic Ulcer</mesh_term>
    <mesh_term>Peptic Ulcer Hemorrhage</mesh_term>
    <mesh_term>Ulcer</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Epinephrine</mesh_term>
    <mesh_term>Epinephryl borate</mesh_term>
    <mesh_term>Hemostatics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
